◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SRT3

Sartorius Aktiengesellschaft (SRT3) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-08-16

Sartorius Aktiengesellschaft (SRT3) operates in the Medical Instruments & Supplies industry and is headquartered in Göttingen, Germany with about 14,279 employees. Its market capitalization is roughly €16 billion. In the fiscal year ended 2025-12-31, SRT3 reported €3.5B in revenue and €155M in net income.

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide.

Interactive charts & full statements →

SRT3 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	€3.5B	€3.4B	€3.4B	€4.2B
Gross Profit	€1.6B	€1.5B	€1.6B	€2.2B
Operating Income (EBIT)	€569M	€437M	€544M	€1.1B
Net Income	€155M	€84M	€206M	€678M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SRT3 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	€912M	€899M	€928M	€884M	€883M	—
Gross Profit	€433M	€414M	€396M	€416M	€431M	—
Operating Income (EBIT)	€164M	€154M	€170M	€132M	€138M	—
Net Income	€66M	€56M	€93M	€32M	€48M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SRT3 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(€51M)	(€51M)	(€98M)	(€86M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SRT3 Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	€0M	(€51M)	(€0M)	€0M	—	—	€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SRT3 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€9.7B	€10.1B	€9.7B	€7.0B	—
Total Liabilities	€5.8B	€6.2B	€7.0B	€4.3B	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SRT3 viewer.

Other Companies in Medical Instruments & Supplies

7749 · Medikit Co.,Ltd. — $41 billion
DIM · Sartorius Stedim Biotech S.A. — $18 billion
3154 · Medius Holdings Co., Ltd. — $17 billion
2276 · Shanghai Conant Optical Co., Ltd. — $17 billion
STMN · Straumann Holding AG — $16 billion
7743 · SEED Co.,Ltd. — $16 billion
6699 · Angelalign Technology Inc. — $16 billion
1066 · Shandong Weigao Group Medical Polymer Company Limited — $15 billion

← SRT All “S” companies SRTA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.